RESTORE.network

Today, 2 articles on spinal cord injury (co)written by Prof Aaron Phillips are published in @NaturePortfolio : doi.org/10.1101/2024.0… doi.org/10.1101/2024.0… Want to know more about beat-to-beat blood pressure monitoring? Go to finapres.com

Research studies say implant can regulate blood pressure in spinal cord injuries ctvnews.ca/calgary/articl…

New study published in Neurology shows transcranial magnetic stimulation (TMS) plus speech therapy can significantly improve speech in people with post-stroke aphasia, even years after stroke. Read more: ucalgary.ca/news/study-rev… #StrokeRecovery #TMS

Honored to have Dr Sean Dukelow from @UCalgaryMed & @HotchkissBrain to visit @TheFlorey and share his work in stroke rehab with the Young Stroke Service and the wider stroke team 🧠 #stroke #strokecare #youngstroke #strokerehab

Kids from a Buffalo Children’s Hospital made an MVP video for their friend Josh Allen Easily the most wholesome thing you’ll see today

Congratulations to Dr. Michael Hill, Dr. Mayank Goyal and the ESCAPE-MeVO team for their important paper in @NEJM today. Unlike in large vessel occlusion, the researchers found endovascular therapy in medium vessels did not improve outcomes at 90 days after ischemic stroke.

🎉 Today marks a truly historic moment – not just for our company, but for the entire spinal cord injury (SCI) community. After more than a decade of pioneering research and unwavering dedication, we have received FDA de novo classification and authorization to market the ARC-EX® System, the world's first non-invasive spinal cord stimulation system proven to improve strength and sensation after chronic SCI. 💫 Here are some key highlights of the ARC-EX System: ⭐️ 90% of clinical trial participants showed improved strength or function* in clinical trials ⭐️ Benefits seen up to 34 years post-injury* in clinical trials ⭐️ Named a @TIME Magazine Best Invention of 2024 For the first time ever, there is an approved therapy to improve hand strength and sensation for people with SCI. This recognition is particularly meaningful because it acknowledges more than just technological innovation – it validates the benefits of this therapy for the millions of people worldwide who dream of regaining movement and independence after SCI. We thank the entire SCI Community for supporting us in our journey to develop and introduce this breakthrough technology. Together, we are not just developing devices; we are reshaping what is possible after spinal cord injury. 🚀 🔗 For more details, read our press release (link in comments). *Moritz, Chet, et al. “Non-invasive spinal cord stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial.” Nature Medicine. 2024. #EmpoweringMovement #SCI #MedicalBreakthrough #Innovation Note: The ARC-EX System is intended to deliver programmed, transcutaneous electrical spinal cord stimulation in conjunction with functional task practice in the clinic to improve hand sensation and strength in individuals between 18 and 75 years old that present with a chronic, non-progressive neurological deficit resulting from an incomplete spinal cord injury (C2-C8 inclusive). Please note that all other ONWARD Medical devices and therapies, including ARC-IM®, ARC-BCI®, and ARC Therapy™ with brain-computer interfaces (BCIs), are investigational and not commercially approved. Patient testimonials reflect individual experiences and outcomes, which may vary. Please review the full product label and clinical study data.

SpineAlly is a new app designed as a health management tool to assist people living with spinal cord injuries.  The app is dual purpose: it facilitates continuous, remote health data collection and monitors key bodily functions ⬇️⬇️

Join us in congratulating Dr. Aaron Phillips on his appointment as the new Associate Dean of Innovation and Commercialization at @UCalgaryMed effective July 1, 2024! 🎉 🌟 Read more: bit.ly/4eoCd7n @LibinInstitute

The Cumming School of Medicine is pleased to announce the appointment of Dr. Aaron Phillips, PhD, as the new associate dean of Innovation & Commercialization effective July 1, 2024. Congrats to Dr. Phillips! Read more: bit.ly/3VLlHqQ @HotchkissBrain @LibinInstitute

📢 ICYMI - the deadline for abstracts has been extended to 6/10 😮‍💨 ‼️

@HotchkissBrain @LibinInstitute @praxis_sci @ICORD_SCI @canadian_spinal

The RESTORE.network hosted a successful meeting @UCalgary bringing together spinal cord injury stakeholders from across Canada. Thank you to all of the speakers and attendees for their valuable input. Let’s unite to advance SCI research! @CummingSchool

The deadline is soon for the 2024 Science & PINS Prize. Aaron Phillips, 2023 Grand Prize Winner, won with research that harnesses particle-to-population–level discoveries to develop new hemodynamic therapeutics for people with neurological conditions. scim.ag/68N

This weekend, Belgian newspaper @tijd published a moving article describing the journey of Julie Verlinden, a trial participant of our research partner, @_NeuroRestore. 📰 In the piece, we learn how Julie’s life changed three years ago when a traumatic car accident left her paralyzed. Eventually, Julie’s struggles with blood pressure instability related to her spinal cord injury (SCI) led her to us. Since enrolling in a feasibility study involving investigational ARC Therapy™ to address her blood pressure challenges, Julie has experienced meaningful improvements to her physical and mental health. Now, she’s sharing her story to give others in the SCI Community hope. 🙏 We are grateful for Julie’s openness, vulnerability, and courage to share her experience to help others. Thank you also to De Tijd for highlighting the often-overlooked issue of SCI-related blood pressure instability which afflicts about three-quarters of people with paralysis. Education is key to addressing this underserved need. *All ONWARD Medical devices and therapies, including but not limited to ARC-IM®, ARC-EX®, ARC-BCI™, and ARC Therapy™, alone or in combination with a brain-computer interface (BCI), are investigational and not available for commercial use. #EmpoweringMovement #spinalcordinjury #ClinicalTrials

Sending warm wishes from the RESTORE Network SCI Team. May your days be filled with joy, relaxation, and good times with loved ones! Cheers to a fantastic holiday season! ❄️

Congratulations to our research partners, Professor Grégoire Courtine and Dr. Jocelyne Bloch and their team at @_NeuroRestore, for making the @nytimes list of “20 Things That Happened for the First Time in 2023.” The newspaper celebrated a “series of surprising and serious events and trends that were unprecedented until now.” The article highlights their milestone achievement documented in Nature earlier this year involving the use of a brain-computer interface (BCI) paired with our ARC Therapy™ to enable a man to walk with augmented control over his paralyzed legs. We are continuing our work around ARC Therapy and BCI and look forward to learning more about the potential of this groundbreaking technology. 🚀 Article here: nytimes.com/2023/12/05/spe… *All ONWARD therapies are investigational and not available for commercial use. #EmpoweringMovement #SCI #NYTimes

‼️New paper out‼️ Grounded in community voices to improve direct care provision… “The ARQS tool offers a promising way for Indigenous patients to provide feedback and for clinics to measure the quality and safety of virtual primary care” @UCalgaryFamMed bmjopenquality.bmj.com/content/12/4/e…

Our new challenge: Making the spinal cord the star of the show. Step aside, brain, it’s spine time! #SpineSpotlight